 | • レポートコード：D0804-15757 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、核医学診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。核医学診断の種類別市場規模（Tc-99m、F-18、その他）、用途別市場規模（腫瘍学、循環器、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bracco Imaging、China Isotope & Radiation、Nordion、Bayer、GE Healthcare、Curium Pharmaceuticals、Eli Lilly、Lantheus、Triad Isotopes、Jubilant Pharma、Novartis、Navidea、SIEMENS、Dongcheng ・地域別グローバル市場分析 2015年-2020年 ・核医学診断の北米市場（アメリカ、カナダ、メキシコ） ・核医学診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核医学診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核医学診断の南米市場（ブラジル、アルゼンチン） ・核医学診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Tc-99m、F-18、その他 ・用途別分析：腫瘍学、循環器、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Diagnostic Nuclear Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Diagnostic Nuclear Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diagnostic Nuclear Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diagnostic Nuclear Drug market has been segmented into:
Tc-99m
F-18
Other
By Application, Diagnostic Nuclear Drug has been segmented into:
Oncology
Cardiology
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diagnostic Nuclear Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Diagnostic Nuclear Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diagnostic Nuclear Drug market.
The report offers in-depth assessment of the growth and other aspects of the Diagnostic Nuclear Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diagnostic Nuclear Drug Market Share Analysis
Diagnostic Nuclear Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diagnostic Nuclear Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diagnostic Nuclear Drug sales, revenue and market share for each player covered in this report.
The major players covered in Diagnostic Nuclear Drug are:
Bracco Imaging
China Isotope & Radiation
Nordion
Bayer
GE Healthcare
Curium Pharmaceuticals
Eli Lilly
Lantheus
Triad Isotopes
Jubilant Pharma
Novartis
Navidea
SIEMENS
Dongcheng
Table of Contents
1 Diagnostic Nuclear Drug Market Overview
1.1 Product Overview and Scope of Diagnostic Nuclear Drug
1.2 Classification of Diagnostic Nuclear Drug by Type
1.2.1 Global Diagnostic Nuclear Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diagnostic Nuclear Drug Revenue Market Share by Type in 2019
1.2.3 Tc-99m
1.2.4 F-18
1.2.5 Other
1.3 Global Diagnostic Nuclear Drug Market by Application
1.3.1 Overview: Global Diagnostic Nuclear Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Nuclear Drug Market by Regions
1.4.1 Global Diagnostic Nuclear Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diagnostic Nuclear Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diagnostic Nuclear Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diagnostic Nuclear Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diagnostic Nuclear Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diagnostic Nuclear Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diagnostic Nuclear Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bracco Imaging SWOT Analysis
2.1.4 Bracco Imaging Product and Services
2.1.5 Bracco Imaging Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 China Isotope & Radiation
2.2.1 China Isotope & Radiation Details
2.2.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 China Isotope & Radiation SWOT Analysis
2.2.4 China Isotope & Radiation Product and Services
2.2.5 China Isotope & Radiation Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nordion
2.3.1 Nordion Details
2.3.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Nordion SWOT Analysis
2.3.4 Nordion Product and Services
2.3.5 Nordion Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GE Healthcare SWOT Analysis
2.5.4 GE Healthcare Product and Services
2.5.5 GE Healthcare Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Curium Pharmaceuticals
2.6.1 Curium Pharmaceuticals Details
2.6.2 Curium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Curium Pharmaceuticals SWOT Analysis
2.6.4 Curium Pharmaceuticals Product and Services
2.6.5 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eli Lilly SWOT Analysis
2.7.4 Eli Lilly Product and Services
2.7.5 Eli Lilly Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lantheus SWOT Analysis
2.8.4 Lantheus Product and Services
2.8.5 Lantheus Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Triad Isotopes
2.9.1 Triad Isotopes Details
2.9.2 Triad Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Triad Isotopes SWOT Analysis
2.9.4 Triad Isotopes Product and Services
2.9.5 Triad Isotopes Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Jubilant Pharma SWOT Analysis
2.10.4 Jubilant Pharma Product and Services
2.10.5 Jubilant Pharma Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Novartis SWOT Analysis
2.11.4 Novartis Product and Services
2.11.5 Novartis Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 Navidea
2.12.1 Navidea Details
2.12.2 Navidea Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Navidea SWOT Analysis
2.12.4 Navidea Product and Services
2.12.5 Navidea Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 SIEMENS SWOT Analysis
2.13.4 SIEMENS Product and Services
2.13.5 SIEMENS Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Dongcheng SWOT Analysis
2.14.4 Dongcheng Product and Services
2.14.5 Dongcheng Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diagnostic Nuclear Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diagnostic Nuclear Drug Players Market Share
3.2.2 Top 10 Diagnostic Nuclear Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diagnostic Nuclear Drug Revenue and Market Share by Regions
4.2 North America Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
4.5 South America Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
5 North America Diagnostic Nuclear Drug Revenue by Countries
5.1 North America Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
5.2 USA Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
6 Europe Diagnostic Nuclear Drug Revenue by Countries
6.1 Europe Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
6.2 Germany Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
6.3 UK Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
6.4 France Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diagnostic Nuclear Drug Revenue by Countries
7.1 Asia-Pacific Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
7.2 China Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
7.5 India Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
8 South America Diagnostic Nuclear Drug Revenue by Countries
8.1 South America Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
8.2 Brazil Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diagnostic Nuclear Drug by Countries
9.1 Middle East & Africa Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diagnostic Nuclear Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Diagnostic Nuclear Drug Market Forecast by Type (2019-2024)
10.3 Tc-99m Revenue Growth Rate (2015-2025)
10.4 F-18 Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Diagnostic Nuclear Drug Market Segment by Application
11.1 Global Diagnostic Nuclear Drug Revenue Market Share by Application (2015-2020)
11.2 Diagnostic Nuclear Drug Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Cardiology Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Diagnostic Nuclear Drug Market Size Forecast (2021-2025)
12.1 Global Diagnostic Nuclear Drug Market Size Forecast (2021-2025)
12.2 Global Diagnostic Nuclear Drug Market Forecast by Regions (2021-2025)
12.3 North America Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
12.4 Europe Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
12.6 South America Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diagnostic Nuclear Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diagnostic Nuclear Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diagnostic Nuclear Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diagnostic Nuclear Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bracco Imaging Corporate Information, Location and Competitors
Table 6. Bracco Imaging Diagnostic Nuclear Drug Major Business
Table 7. Bracco Imaging Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 8. Bracco Imaging SWOT Analysis
Table 9. Bracco Imaging Diagnostic Nuclear Drug Product and Solutions
Table 10. Bracco Imaging Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. China Isotope & Radiation Corporate Information, Location and Competitors
Table 12. China Isotope & Radiation Diagnostic Nuclear Drug Major Business
Table 13. China Isotope & Radiation Diagnostic Nuclear Drug Total Revenue (USD Million) (2018-2019)
Table 14. China Isotope & Radiation SWOT Analysis
Table 15. China Isotope & Radiation Diagnostic Nuclear Drug Product and Solutions
Table 16. China Isotope & Radiation Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Nordion Corporate Information, Location and Competitors
Table 18. Nordion Diagnostic Nuclear Drug Major Business
Table 19. Nordion Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 20. Nordion SWOT Analysis
Table 21. Nordion Diagnostic Nuclear Drug Product and Solutions
Table 22. Nordion Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Corporate Information, Location and Competitors
Table 24. Bayer Diagnostic Nuclear Drug Major Business
Table 25. Bayer Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 26. Bayer SWOT Analysis
Table 27. Bayer Diagnostic Nuclear Drug Product and Solutions
Table 28. Bayer Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GE Healthcare Corporate Information, Location and Competitors
Table 30. GE Healthcare Diagnostic Nuclear Drug Major Business
Table 31. GE Healthcare Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 32. GE Healthcare SWOT Analysis
Table 33. GE Healthcare Diagnostic Nuclear Drug Product and Solutions
Table 34. GE Healthcare Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Curium Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Curium Pharmaceuticals Diagnostic Nuclear Drug Major Business
Table 37. Curium Pharmaceuticals Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 38. Curium Pharmaceuticals SWOT Analysis
Table 39. Curium Pharmaceuticals Diagnostic Nuclear Drug Product and Solutions
Table 40. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eli Lilly Corporate Information, Location and Competitors
Table 42. Eli Lilly Diagnostic Nuclear Drug Major Business
Table 43. Eli Lilly Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 44. Eli Lilly SWOT Analysis
Table 45. Eli Lilly Diagnostic Nuclear Drug Product and Solutions
Table 46. Eli Lilly Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lantheus Corporate Information, Location and Competitors
Table 48. Lantheus Diagnostic Nuclear Drug Major Business
Table 49. Lantheus Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 50. Lantheus SWOT Analysis
Table 51. Lantheus Diagnostic Nuclear Drug Product and Solutions
Table 52. Lantheus Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Triad Isotopes Corporate Information, Location and Competitors
Table 54. Triad Isotopes Diagnostic Nuclear Drug Major Business
Table 55. Triad Isotopes Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 56. Triad Isotopes SWOT Analysis
Table 57. Triad Isotopes Diagnostic Nuclear Drug Product and Solutions
Table 58. Triad Isotopes Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Jubilant Pharma Corporate Information, Location and Competitors
Table 60. Jubilant Pharma Diagnostic Nuclear Drug Major Business
Table 61. Jubilant Pharma Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 62. Jubilant Pharma SWOT Analysis
Table 63. Jubilant Pharma Diagnostic Nuclear Drug Product and Solutions
Table 64. Jubilant Pharma Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Novartis Corporate Information, Location and Competitors
Table 66. Novartis Diagnostic Nuclear Drug Major Business
Table 67. Novartis Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 68. Novartis SWOT Analysis
Table 69. Novartis Diagnostic Nuclear Drug Product and Solutions
Table 70. Novartis Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Navidea Corporate Information, Location and Competitors
Table 72. Navidea Diagnostic Nuclear Drug Major Business
Table 73. Navidea Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 74. Navidea SWOT Analysis
Table 75. Navidea Diagnostic Nuclear Drug Product and Solutions
Table 76. Navidea Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. SIEMENS Corporate Information, Location and Competitors
Table 78. SIEMENS Diagnostic Nuclear Drug Major Business
Table 79. SIEMENS Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 80. SIEMENS SWOT Analysis
Table 81. SIEMENS Diagnostic Nuclear Drug Product and Solutions
Table 82. SIEMENS Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Dongcheng Corporate Information, Location and Competitors
Table 84. Dongcheng Diagnostic Nuclear Drug Major Business
Table 85. Dongcheng Diagnostic Nuclear Drug Total Revenue (USD Million) (2017-2018)
Table 86. Dongcheng SWOT Analysis
Table 87. Dongcheng Diagnostic Nuclear Drug Product and Solutions
Table 88. Dongcheng Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Diagnostic Nuclear Drug Revenue (Million USD) by Players (2015-2020)
Table 90. Global Diagnostic Nuclear Drug Revenue Share by Players (2015-2020)
Table 91. Global Diagnostic Nuclear Drug Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Diagnostic Nuclear Drug Revenue Market Share by Regions (2015-2020)
Table 93. North America Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
Table 94. North America Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Table 95. Europe Diagnostic Nuclear Drug Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Diagnostic Nuclear Drug Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Diagnostic Nuclear Drug Revenue by Countries (2015-2020)
Table 98. South America Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Diagnostic Nuclear Drug Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Table 101. Global Diagnostic Nuclear Drug Revenue (Million USD) by Type (2015-2020)
Table 102. Global Diagnostic Nuclear Drug Revenue Share by Type (2015-2020)
Table 103. Global Diagnostic Nuclear Drug Revenue Forecast by Type (2021-2025)
Table 104. Global Diagnostic Nuclear Drug Revenue by Application (2015-2020)
Table 105. Global Diagnostic Nuclear Drug Revenue Share by Application (2015-2020)
Table 106. Global Diagnostic Nuclear Drug Revenue Forecast by Application (2021-2025)
Table 107. Global Diagnostic Nuclear Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diagnostic Nuclear Drug Picture
Figure 2. Global Diagnostic Nuclear Drug Revenue Market Share by Type in 2019
Figure 3. Tc-99m Picture
Figure 4. F-18 Picture
Figure 5. Other Picture
Figure 6. Diagnostic Nuclear Drug Revenue Market Share by Application in 2019
Figure 7. Oncology Picture
Figure 8. Cardiology Picture
Figure 9. Other Picture
Figure 10. Global Diagnostic Nuclear Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Diagnostic Nuclear Drug Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Diagnostic Nuclear Drug Revenue Market Share in 2019
Figure 19. Global Top 10 Players Diagnostic Nuclear Drug Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Diagnostic Nuclear Drug Revenue Market Share by Regions (2015-2020)
Figure 23. Global Diagnostic Nuclear Drug Revenue Market Share by Regions in 2018
Figure 24. North America Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 25. Europe Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 27. South America Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 29. North America Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Figure 30. North America Diagnostic Nuclear Drug Revenue Market Share by Countries in 2019
Figure 31. USA Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 32. Canada Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 34. Europe Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Diagnostic Nuclear Drug Revenue Market Share by Countries in 2019
Figure 36. Germany Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 37. UK Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 38. France Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 39. Russia Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 40. Italy Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Diagnostic Nuclear Drug Revenue Market Share by Countries in 2019
Figure 43. China Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 44. Japan Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 45. Korea Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 46. India Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 48. South America Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Figure 49. South America Diagnostic Nuclear Drug Revenue Market Share by Countries in 2019
Figure 50. Brazil Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 55. UAE Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Diagnostic Nuclear Drug Revenue and Growth Rate (2015-2020)
Figure 58. Global Diagnostic Nuclear Drug Revenue Share by Type (2015-2020)
Figure 59. Global Diagnostic Nuclear Drug Revenue Share by Type in 2019
Figure 60. Global Diagnostic Nuclear Drug Market Share Forecast by Type (2021-2025)
Figure 61. Global Tc-99m Revenue Growth Rate (2015-2020)
Figure 62. Global F-18 Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global Diagnostic Nuclear Drug Revenue Share by Application (2015-2020)
Figure 65. Global Diagnostic Nuclear Drug Revenue Share by Application in 2019
Figure 66. Global Diagnostic Nuclear Drug Market Share Forecast by Application (2021-2025)
Figure 67. Global Oncology Revenue Growth Rate (2015-2020)
Figure 68. Global Cardiology Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Nuclear Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Diagnostic Nuclear Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Diagnostic Nuclear Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
Figure 74. Europe Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
Figure 76. South America Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
核医学診断（SPECTおよびPET）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Medicine Diagnostic (SPECT and PET) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The N…- 治療用核薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Nuclear Drug for Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Drug for…
- 医療用核イメージングシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medical Nuclear Imaging System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Medical Nuclea…
- 核LED照明の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Nuclear LED Lighting market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 使用済み核燃料（SNF）用ドライ中間保管の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dry Interim Storage for Spent Nuclear Fuel (SNF) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…